SPL Mapping FHIR Implementation Guide
0.1.0 - Build CI
SPL Mapping FHIR Implementation Guide
0.1.0 - Build CI
SPL Mapping FHIR Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.org/fhir/us/spl/ValueSet/splDocumentCodes | Version: 0.1.0 | |||
| Standards status: Trial-use | Maturity Level: 1 | Computable Name: SPLDocumentCodes | ||
Copyright/Legal: This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. |
||||
Document Codes for SPL Product Submission documents
References
http://loinc.org where SYSTEM = ^FDA product label
Expansion based on Loinc v2.77
This value set contains 95 concepts.
| Code | System | Display |
| 101437-2 | http://loinc.org | FDA product label Intentional animal genomic alteration label |
| 104085-6 | http://loinc.org | FDA product label Cosmetic facility registration |
| 104086-4 | http://loinc.org | FDA product label Cosmetic facility registration-amendment |
| 104087-2 | http://loinc.org | FDA product label Cosmetic facility registration-abbreviated renewal |
| 104088-0 | http://loinc.org | FDA product label Cosmetic facility registration-cancellation |
| 104089-8 | http://loinc.org | FDA product label Cosmetic facility registration-biennial renewal |
| 104090-6 | http://loinc.org | FDA product label Cosmetic-abbreviated renewal |
| 104091-4 | http://loinc.org | FDA product label Animal drug for further processing |
| 34390-5 | http://loinc.org | FDA product label Human OTC drug label |
| 34391-3 | http://loinc.org | FDA product label Human prescription drug label |
| 45129-4 | http://loinc.org | FDA product label Human prescription drug label with highlights |
| 50565-1 | http://loinc.org | FDA product label OTC - Keep out of reach of children section |
| 50566-9 | http://loinc.org | FDA product label OTC - Stop use section |
| 50567-7 | http://loinc.org | FDA product label OTC - When using section |
| 50568-5 | http://loinc.org | FDA product label OTC - Ask doctor or pharmacist section |
| 50569-3 | http://loinc.org | FDA product label OTC - Ask doctor section |
| 50570-1 | http://loinc.org | FDA product label OTC - Do not use section |
| 50571-9 | http://loinc.org | FDA product label VFD Type C medicated feed animal drug label |
| 50572-7 | http://loinc.org | FDA product label VFD Type B medicated feed animal drug label |
| 50573-5 | http://loinc.org | FDA product label OTC Type C medicated feed animal drug label |
| 50574-3 | http://loinc.org | FDA product label OTC Type B medicated feed animal drug label |
| 50575-0 | http://loinc.org | FDA product label VFD Type A medicated article animal drug label |
| 50576-8 | http://loinc.org | FDA product label OTC Type A medicated article animal drug label |
| 50577-6 | http://loinc.org | FDA product label OTC animal drug label |
| 50578-4 | http://loinc.org | FDA product label Prescription animal drug label |
| 50740-0 | http://loinc.org | FDA product label Guaranteed analysis of feed section |
| 50741-8 | http://loinc.org | FDA product label Safe handling warning section |
| 50742-6 | http://loinc.org | FDA product label Environmental warning section |
| 50743-4 | http://loinc.org | FDA product label Food safety warning section |
| 50744-2 | http://loinc.org | FDA product label Information for owners or caregivers section |
| 50745-9 | http://loinc.org | FDA product label Veterinary indications section |
| 51725-0 | http://loinc.org | FDA product label Establishment registration |
| 51726-8 | http://loinc.org | FDA product label NDC labeler code request |
| 51727-6 | http://loinc.org | FDA product label Inactive ingredient section |
| 51941-3 | http://loinc.org | FDA product label Back panel of package |
| 51942-1 | http://loinc.org | FDA product label Side panel of package Right |
| 51943-9 | http://loinc.org | FDA product label Side panel of package Left |
| 51944-7 | http://loinc.org | FDA product label Side panel of package |
| 51945-4 | http://loinc.org | FDA product label Principal display panel of package |
| 51946-2 | http://loinc.org | FDA product label Top panel of package |
| 51947-0 | http://loinc.org | FDA product label Bottom panel of package |
| 51948-8 | http://loinc.org | FDA product label Flap panel of package |
| 53404-0 | http://loinc.org | FDA product label Vaccine label |
| 53405-7 | http://loinc.org | FDA product label Non-standardized allergenic label |
| 53406-5 | http://loinc.org | FDA product label Licensed vaccine bulk intermediate label |
| 53407-3 | http://loinc.org | FDA product label Licensed blood intermediate/paste label |
| 53408-1 | http://loinc.org | FDA product label Licensed minimally manipulated cells label |
| 53409-9 | http://loinc.org | FDA product label Bulk ingredient |
| 53410-7 | http://loinc.org | FDA product label No change notification |
| 53411-5 | http://loinc.org | FDA product label Out of business notification |
| 53412-3 | http://loinc.org | FDA product label Residue warning section |
| 53413-1 | http://loinc.org | FDA product label OTC - Questions section |
| 53414-9 | http://loinc.org | FDA product label OTC - Pregnancy or breast feeding section |
| 55105-1 | http://loinc.org | FDA product label OTC - Purpose section |
| 55106-9 | http://loinc.org | FDA product label OTC - Active ingredient section |
| 55439-4 | http://loinc.org | FDA product label Medical device |
| 58474-8 | http://loinc.org | FDA product label Cosmetic |
| 58475-5 | http://loinc.org | FDA product label Medical food |
| 58476-3 | http://loinc.org | FDA product label Dietary supplement |
| 60682-2 | http://loinc.org | FDA product label Standardized allergenic |
| 60683-0 | http://loinc.org | FDA product label Plasma derivative |
| 60684-8 | http://loinc.org | FDA product label Cellular therapy |
| 63417-0 | http://loinc.org | FDA product label Indexing - Indication |
| 68498-5 | http://loinc.org | FDA product label Patient medication information section |
| 69403-4 | http://loinc.org | FDA product label OTC medical device label |
| 69404-2 | http://loinc.org | FDA product label Prescription medical device label |
| 69718-5 | http://loinc.org | FDA product label Statement of identity section |
| 69719-3 | http://loinc.org | FDA product label Health claim section |
| 69968-6 | http://loinc.org | FDA product label NDC labeler code inactivation |
| 70097-1 | http://loinc.org | FDA product label Establishment de-registration |
| 71743-9 | http://loinc.org | FDA product label Generic drug facility identification submission |
| 72090-4 | http://loinc.org | FDA product label Identification of CBER-regulated generic drug facility |
| 72871-7 | http://loinc.org | FDA product label NDC labeler code request - animal drug |
| 75030-7 | http://loinc.org | FDA product label Wholesale drug distributors and third-party logistics facility registration |
| 75031-5 | http://loinc.org | FDA product label Human compounded drug label |
| 77573-4 | http://loinc.org | FDA product label Withdrawal of wholesale drug distributors and third-party logistics facility report |
| 77647-6 | http://loinc.org | FDA product label Animal compounded drug label |
| 77648-4 | http://loinc.org | FDA product label Indexing - biologic or drug substance |
| 78744-0 | http://loinc.org | FDA product label Drug for further processing label |
| 78745-7 | http://loinc.org | FDA product label Recombinant deoxyribonucleic acid construct label |
| 81203-2 | http://loinc.org | FDA product label Bulk ingredient - animal drug |
| 81204-0 | http://loinc.org | FDA product label NDC labeler code inactivation - animal drug |
| 85480-2 | http://loinc.org | FDA product label Establishment registration exempt notification |
| 85481-0 | http://loinc.org | FDA product label Blood establishment registration and product listing |
| 85482-8 | http://loinc.org | FDA product label Human cell and tissue establishment registration and product listing |
| 85484-4 | http://loinc.org | FDA product label Establishment temporary inactivation notification |
| 86444-7 | http://loinc.org | FDA product label Manufacturing establishment information |
| 86446-2 | http://loinc.org | FDA product label Blood establishment registration and product listing change in information |
| 86447-0 | http://loinc.org | FDA product label Human cell and tissue establishment registration and product listing change in information |
| 86448-8 | http://loinc.org | FDA product label Human salvaged drug |
| 89600-1 | http://loinc.org | FDA product label FDA-initiated compliance action drug registration and listing inactivation |
| 93372-1 | http://loinc.org | FDA product label Indexing - national clinical trial number |
| 93723-5 | http://loinc.org | FDA product label Indexing - drug interactions |
| 98075-5 | http://loinc.org | FDA product label Animal cells, tissues, and cell and tissue based product label |
| 99282-6 | http://loinc.org | FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2020+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.us.spl#0.1.0 based on FHIR 4.3.0. Generated 2024-05-02
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change